Ophthalmoplegia and ptosis: mitochondrial toxicity in patients receiving HIV therapy.
Pfeffer
G
G
Division of Neurology and Department of Pathology & Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.
Côté
H C F
HC
Montaner
J S
JS
Li
C C
CC
Jitratkosol
M
M
Mezei
M M
MM
D019380:Anti-HIV Agents / Q000009:adverse effects; D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects*; D001763:Blepharoptosis / Q000139:chemically induced / Q000378:metabolism / Q000503:physiopathology; D004272:DNA, Mitochondrial / Q000187:drug effects; D016049:Didanosine / Q000009:adverse effects; D020022:Genetic Predisposition to Disease / Q000235:genetics; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D008060:Lipodystrophy / Q000139:chemically induced / Q000378:metabolism / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D008928:Mitochondria / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D028361:Mitochondrial Diseases / Q000139:chemically induced* / Q000235:genetics / Q000503:physiopathology*; D018482:Muscle, Skeletal / Q000187:drug effects / Q000473:pathology / Q000503:physiopathology; D009154:Mutation / Q000235:genetics; D009801:Oculomotor Muscles / Q000187:drug effects / Q000473:pathology / Q000503:physiopathology; D009886:Ophthalmoplegia / Q000139:chemically induced / Q000378:metabolism / Q000503:physiopathology; D017246:Ophthalmoplegia, Chronic Progressive External / Q000139:chemically induced* / Q000378:metabolism / Q000503:physiopathology*; D020127:Recovery of Function / Q000502:physiology; D012307:Risk Factors; D013995:Time
D019380:Anti-HIV Agents; D004272:DNA, Mitochondrial; D016049:Didanosine